--- title: "Blast and Cruise: What It Is and the Real Risks" description: "Blast and cruise explained: how it differs from a cycle, lasting HPTA suppression, why monitoring becomes mandatory." lang: en dateModified: 2026-05-23 canonical: https://anaprotokol.com/en/guides/blast-and-cruise-explained --- # Blast and Cruise: What It Is and the Real Risks **Blast and cruise** — often shortened to B&C — names a practice that sits apart from a classic cycle: you alternate "blast" phases (cycle at supraphysiological doses) with "cruise" phases (physiological dose, equivalent to TRT), without ever stopping exogenous testosterone. No PCT, no off-period. It is a choice that turns an occasional cycle into a lifelong hormonal commitment. This guide describes the structure, the consequences and the risks of B&C. It does not recommend it nor condemn it — it lays out what it actually is, and what anyone considering it should integrate. For the comparable frame of a classic cycle, see the [how to design a steroid cycle](/en/guides/how-to-design-a-steroid-cycle) pillar; for medical TRT, see [TRT protocol guide](/en/guides/trt-protocol-guide). ## Definition: blast and cruise Blast and cruise alternates two phases, never stopping the testosterone. - **The blast**: a 10 to 16-week phase at a supraphysiological dose, similar to a classic cycle. Often a high testosterone base + an added compound (deca, masteron, sometimes tren). - **The cruise**: a phase of several weeks to several months at a physiological dose, typically 100 to 200 mg of [testosterone enanthate](/en/molecule/test-enanthate) per week — equivalent to a [TRT](/en/guides/trt-protocol-guide) protocol. The crucial difference with a classic cycle: there is no PCT and no testosterone-free period. The HPTA is suppressed permanently; natural testosterone will not come back as long as the B&C lasts — and in many cases, will not come back after either [1]. > The blast/cruise ratio varies across practitioners. A common logic is "blast = cruise" (e.g. 12 weeks of blast followed by 12 weeks of cruise), which works out to roughly two blasts per year. ## Structural difference with a classic cycle | Criterion | Classic cycle | Blast and cruise | | --- | --- | --- | | Testosterone-free periods | Yes (PCT + off) | No, never | | PCT | Mandatory at cycle end | Absent by construction | | Target HPTA recovery | Yes, after each cycle | No, permanent suppression assumed | | Natural production restored | PCT target | Explicitly forgone | | Natural fertility | Preserved off-cycle | Compromised as long as B&C lasts (and often beyond) | | Frame of reference | Seasonal (1 to 2 cycles/year) | Continuous, lifelong commitment | | Medical supervision | Wanted, sometimes missing | Near-mandatory to stay framed | On the purely hormonal side, a B&C practitioner sits in the same state as a patient on lifelong TRT — with additional supraphysiological phases on top. The testosterone supplementation is not designed to ever stop. ## Why some practitioners run B&C ### Arguments people make for it - Avoid the post-PCT troughs and the fatigue that follows every classic cycle. - Hold on to a larger share of cycle gains — PCT always gives some back. - Simplify planning: no more PCT windows, no more "time on = time off" math. - Acknowledge that past a certain number of cumulative cycles, natural recovery does not happen anyway — so own it. ### Arguments against - Definitive forfeit of endogenous testosterone production — hormonal dependence becomes permanent. - Near-systematic infertility during B&C, partially reversible in some, irreversible in others (the long-term data is thin). - Major cardiovascular accumulation: chronically elevated hematocrit, degraded lipid profile, left ventricular hypertrophy associated with repeated supraphysiological cycles. Over 20-30 years, the consequences are poorly documented but concerning [3]. - No window to let certain markers (liver, lipids) return to baseline. - Lifelong commitment to sourcing, cost, and side-effect management without a pause. ## Who actually runs B&C B&C is widespread in several sub-populations: professional bodybuilders (where coming off has become rare), elite "tested" or untested powerlifters, some lifters past 30-35 who find their HPTA recovery becoming difficult after several cumulative cycles. It also shows up, more problematically, in amateurs who slide into B&C out of PCT fatigue rather than out of a deliberate decision. > Sliding into B&C because "PCT is too rough to recover from anymore" is usually a sign that you have run too many cycles too close together, or cycles too long without giving the HPTA time to recover. A medical opinion (endocrinologist) is preferable to a default switch. ## Monitoring: non-negotiable Without a pause, there is no natural window for certain markers to return to baseline. Monitoring becomes the central element of B&C management. Every 3 to 6 months minimum, more frequent during blast phases [6]. - **Hematocrit**: permanent testosterone chronically elevates it. Past 54-55%, blood donation becomes a regular option. See [hematocrit and steroids](/en/guides/hematocrit-and-steroids). - **Lipid panel (HDL/LDL/ApoB)**: chronic degradation is expected. Cardiology follow-up advised after a few years of B&C. - **Blood pressure**: regular at-home measurement, antihypertensive treatment if needed. - **Estradiol**: fine-grained management — an AI may be needed at a modulated dose depending on the phase. - **Renal and hepatic function**: regular panels, especially during blasts. - **Cardiac markers**: cardiac ultrasound every 1-2 years to monitor left ventricular hypertrophy, strongly associated with chronic steroid use. The detailed schedule sits in the [blood work on cycle](/en/guides/blood-work-on-cycle) guide; the specific hormonal markers in [hormonal markers on cycle](/en/guides/hormonal-markers-on-cycle). ## Getting off B&C: is it possible? Coming off a B&C run that has lasted several years is possible, but with a markedly lower probability of natural recovery than after an occasional cycle. The exit protocol relies on the same tools as a classic PCT — SERM, sometimes preparatory HCG — but extended in time (several months). Follow-up by an endocrinologist familiar with the topic is strongly recommended: self-managing the exit is risky [5]. The other option, more pragmatic for many, is to move from B&C to a medically-supervised lifelong TRT: the supraphysiological dose is dropped, but the physiological-dose testosterone supplementation is kept for life. See [TRT protocol guide](/en/guides/trt-protocol-guide). > On fertility: spermatogenesis is suppressed under B&C. Any plan for fatherhood has to be anticipated — sperm collection and freezing before B&C, or a fertility-restart protocol (HCG + hMG/FSH, several months) in coordination with a physician. See [TRT and fertility](/en/guides/trt-and-fertility). ## FAQ ### Is B&C equivalent to lifelong TRT? On HPTA suppression and dependence on exogenous supply: yes. On doses and cardiovascular risk: no. Medical TRT aims to restore testosterone to a physiological level to treat hypogonadism — the dose and blood markers are calibrated to stay inside the normal range. B&C alternates physiological phases (cruise) with supraphysiological phases (blast) — that second phase is what adds the cumulative risks specific to a classic cycle, repeated twice a year without a pause. ### Can you return to natural testosterone production after a long B&C? Possible, never guaranteed. The longer the B&C lasted (years), the lower the probability of full recovery. Some users partially recover after an extended SERM + HCG protocol; others retain a persistent hypogonadism that requires lifelong TRT [1]. Without medical follow-up, the exit is risky — this is one of the situations where self-management clearly shows its limits. ### After how many classic cycles does the community consider B&C? There is no objective threshold. Some practitioners never switch; others consider B&C after 4 to 6 cumulative cycles when post-PCT recovery becomes markedly harder. The decision should not be made on the back of one rough PCT but after several post-PCT hormonal panels showing durably incomplete HPTA recovery — ideally with a medical opinion. A default switch = wrong reason.